Mode
Text Size
Log in / Sign up

Clinical Trial Search

Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.

Phase
Intervention
Population
Results posted

30 closest matches · ranked by relevance

Phase 2 N=75 Peanut Epicutaneous Phase II Immunotherapy Clinical Trial

Peanut Hypersensitivity · Food Hypersensitivity · Hypersensitivity
Primary: Percentage of Subjects With a Successful Treatment Response — 12.0; 45.8; 48.0 percentage of participants — p=0.005
National Institute of Allergy and Infectious… Results Aug 2016 3.2% serious AE View details

Phase 2 N=146 Peanut Oral Immunotherapy in Children

Peanut Hypersensitivity
Primary: Percentage of Participants Desensitized to Peanut Protein After 134 Weeks of Oral Immunotherapy (OIT) — 71; 2 Percentage of Participants — p=<0.0001
National Institute of Allergy and Infectious… Results Jan 2020 4.8% serious AE View details

Phase 2 N=10 Oral Immunotherapy for Peanut Allergy (PMIT)

Food Hypersensitivity
Primary: The Amount of Peanut Protein Ingested Before An Allergic Reaction is Observed During the Double-blind, Placebo Controlled Food Challenge (DBPCFC) After Completing…
University of North Carolina, Chapel Hill Results May 2017 0.0% serious AE View details

Phase 2 N=20 Milk Patch for Eosinophilic Esophagitis

Eosinophilic Esophagitis · Milk Allergy
Primary: Change in Maximum Esophageal Eosinophil Count From Baseline to End of Double-blind Treatment. (Intent to Treat Population) — -10.8; -24.2 Eosinophils (Eos)/high power…
Children's Hospital of Philadelphia Results Jul 2019 5.0% serious AE View details

Phase 2 N=60 Multi Immunotherapy to Test Tolerance and Xolair

Food Allergy
Primary: The Number of Participants Able to Tolerate an Oral Food Challenge to 2,000 mg at Least of 2 Allergens at Week 36 (i.e. the End of the Randomized Withdrawal/Tolerance…
Kari Christine Nadeau Results Dec 2017 0.8% serious AE View details

Phase 2 N=50 FARE Peanut SLIT and Early Tolerance Induction

Peanut Hypersensitivity · Food Allergy · Food Hypersensitivity
Primary: Desensitization After 36 Months of Peanut SLIT or Placebo SLIT — 4.9; 2.5 score on a scale — p=0.002
University of North Carolina, Chapel Hill Results Dec 2021 2.0% serious AE View details